Healthcare budgets in countries around the world are, in aggregate, expected to increase by 10 percent by 2030, according to a survey of more than 120 executives at the world’s top biopharmaceutical companies, conducted by Strategy&, PwC’s strategy consulting business. But some researchers’ expectations put the number much higher, at 42 percent.
Read more in strategyand.pwc.
(Visited 51 times, 1 visits today)
